• Mon, April 11, 2022
  • Tue, April 12, 2022

Tazeen Ahmad Downgraded (BCRX) to Hold and Held Target at $14 on, Apr 11th, 2022

Tazeen Ahmad of B of A Securities, Downgraded "BioCryst Pharmaceuticals, Inc." (BCRX) to Hold and Held Target at $14 on, Apr 11th, 2022.

Tazeen, nor any peers, have made any analyst calls on BCRX in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30

Like: 👍